Affiliation: University of South Florida
- Elvitegravir: a once-daily inhibitor of HIV-1 integraseTodd Wills
Division of Infectious Disease and International Medicine, University of South Florida College of Medicine, 1 Tampa General Circle, Tampa, FL, USA
Expert Opin Investig Drugs 21:395-401. 2012..It is the second member of the HIV-1 IN inhibitor class, following raltegravir. Co-administration with a CYP3A inhibitor, such as ritonavir or cobicistat, substantially increases EVG plasma exposure and prolongs elimination half-life...